Definition of Metabolic Syndrome
2004/01/26 by Scott M. Grundy, H. Bryan Brewer, H Bryan Brewer +3 · 5,995 citations
Medicine · #Cardiology #Diabetes, Cardiovascular Risks, and Lipoproteins #Diet, Metabolism, and Disease #Internal medicine #Medicine #Metabolic syndrome #Natural Antidiabetic Agents Studies #Obesity
paper · doi:10.1161/01.cir.0000111245.75752.c6
published in Circulation 109(3), 433-438 (Lippincott Williams & Wilkins)
openalex publication_date 2004/01/26 · openalex created_date 2016/06/24 · openalex updated_date 2026/08/02
Cited by
- Diagnosis and Management of the Metabolic Syndrome
- Defective FXR-SHP Regulation in Obesity Aberrantly Increases miR-802 Expression, Promoting Insulin Resistance and Fatty Liver
- Adipose Tissue as an Endocrine Organ
- Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
- A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
- Food insecurity is associated with obesity and abdominal obesity among older adults: A cross-sectional analysis of ELSA study
- Query Cost Estimation in Relational Database Management System.
- Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
- Obesity-related non-communicable diseases: South Asians vs White Caucasians
- The Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio as a Risk Marker for Metabolic Syndrome and Cardiovascular Disease
- Electronic health record phenotyping improves detection and screening of type 2 diabetes in the general United States population: A cross-sectional, unselected, retrospective study
- Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy
- Metabolic psychiatry targeting metabolic dysregulation in mental health
- Cardiometabolic Syndrome: An Update on Available Mouse Models
- Physical Activity, Telomere Length, and Cardiometabolic Syndrome in Older Women: The Cardiovascular Health Study
- The association of periodontal diseases with metabolic syndrome and obesity
- Mitochondrial energy metabolism and redox responses to hypertriglyceridemia
- The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?
- European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
- The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease
- Key Elements of Plant-Based Diets Associated with Reduced Risk of Metabolic Syndrome
- Diabetic Retinopathy Preferred Practice Pattern®
- L-Arginine and Hypertension
- The role of testosterone in the metabolic syndrome: A review
- Sarcopenia using muscle mass prediction model and cognitive impairment: A longitudinal analysis from the English longitudinal study on ageing
- Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss
- Multiple chronic conditions: prevalence, health consequences, and implications for quality, care management, and costs. [europepmc]
- Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. [europepmc]
- Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. [europepmc]
- Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. [europepmc]
- Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. [europepmc]
- Ethnic differences in hepatic steatosis: an insulin resistance paradox? [europepmc]
- Epidemiology of gout. [europepmc]
- Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? [europepmc]
- Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. [europepmc]
- Diabetes and hypertension: is there a common metabolic pathway? [europepmc]
- Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. [europepmc]
- Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. [europepmc]
- Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). [europepmc]
- Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. [europepmc]
- Age and cancer risk: a potentially modifiable relationship. [europepmc]
- Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. [europepmc]
- Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. [europepmc]
- Oxidative stress in obesity: a critical component in human diseases. [europepmc]
- Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA). [europepmc]
- The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. [europepmc]
- The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited. [europepmc]
- Metabolism disrupting chemicals and metabolic disorders. [europepmc]
- Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. [europepmc]
- Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation. [europepmc]
- Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. [europepmc]